Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice
lacking the LDL receptor.
Johnson LA, Arbones-Mainar JM, Fox RG, Pendse AA, Altenburg MK, Kim HS, Maeda N
Nobuyo Maeda on 2/22/2012
Volume : Pages
60 : 2285 - 2294
We investigated the differential roles of apolipoprotein E (apoE) isoforms in
modulating diabetic dyslipidemia-a potential cause of the increased
cardiovascular disease risk of patients with diabetes.
Investigators with authorship
University of North Carolina
Neuropathy & Neurocognition
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!